Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.28
+4.58 (1.83%)
AAPL  271.40
+8.00 (3.04%)
AMD  277.47
-0.79 (-0.28%)
BAC  54.05
+0.54 (1.00%)
GOOG  335.04
+2.27 (0.68%)
META  683.39
+6.52 (0.96%)
MSFT  431.21
+10.95 (2.61%)
NVDA  200.63
+2.28 (1.15%)
ORCL  179.29
+0.95 (0.54%)
TSLA  405.91
+17.01 (4.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.